Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
With
National Institute of Neurological Disorders and Stroke (NINDS)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Black or Hispanic
Age 18 years or older
English or Spanish speaking
Patients who have had an ischemic or hemorrhagic stroke
Modified Rankin scale score of ≤ 3
Average screening SBP ≥ 140 mm Hg from three BP readings taken at two separate visits with a validated automated device
Receiving care at the study site for at least 6 months and planning to continue receiving care at the site for the next two years.
You may not be if
Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that he/she could not complete all requested tasks including using the HBPTM or interacting with the NCM if he/she were to be randomized to the intervention group)
Participation in other clinical trials
Diagnosis of cognitive dysfunction or significant psychiatric comorbidity (as indicated in medical record)
Patients with upper arm circumference ≥ 52 cm, the maximum limit of the extra-large BP cuff
Diagnosis of dialysis or end stage renal disease
Relocating out of area or extended travel during study period
Significant verbal speech impairment; unable to participate in intervention telephone sessions
Pregnant women
Clareo Health | Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors